EDUARDO MAGALHAES REGO
EDUARDO MAGALHAES REGO
University of São Paulo - Faculdade de Medicina
Verified email at fm.usp.br
Title
Cited by
Cited by
Year
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification
D Ruggero, S Grisendi, F Piazza, E Rego, F Mari, PH Rao, ...
Science 299 (5604), 259-262, 2003
4432003
Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita
A Yoon, G Peng, Y Brandenburg, O Zollo, W Xu, E Rego, D Ruggero
Science 312 (5775), 902-906, 2006
3822006
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
M Barna, A Pusic, O Zollo, M Costa, N Kondrashov, E Rego, PH Rao, ...
Nature 456 (7224), 971-975, 2008
3672008
Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML …
EM Rego, LZ He, RP Warrell, ZG Wang, PP Pandolfi
Proceedings of the National Academy of Sciences 97 (18), 10173-10178, 2000
2192000
Role of promyelocytic leukemia (PML) protein in tumor suppression
EM Rego, ZG Wang, D Peruzzi, LZ He, C Cordon-Cardo, PP Pandolfi
The Journal of experimental medicine 193 (4), 521-530, 2001
1772001
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
S Wei, S Kozono, L Kats, M Nechama, W Li, J Guarnerio, M Luo, MH You, ...
Nature medicine 21 (5), 457-466, 2015
1712015
Two critical hits for promyelocytic leukemia
LZ He, M Bhaumik, C Tribioli, EM Rego, S Ivins, A Zelent, PP Pandolfi
Molecular cell 6 (5), 1131-1141, 2000
1642000
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
MA Sanz, P Fenaux, MS Tallman, EH Estey, B Löwenberg, T Naoe, ...
Blood 133 (15), 1630-1643, 2019
1562019
Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
FC Guibal, M Alberich-Jorda, H Hirai, A Ebralidze, E Levantini, ...
Blood, The Journal of the American Society of Hematology 114 (27), 5415-5425, 2009
1512009
Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines
RH Jácomo, RAM Melo, FR Souto, ÉR de Mattos, CT de Oliveira, ...
Haematologica 92 (10), 1431-1432, 2007
1332007
Determination of P‐glycoprotein, MDR‐related protein 1, breast cancer resistance protein, and lung‐resistance protein expression in leukemic stem cells of acute myeloid leukemia
LL de Figueiredo‐Pontes, MCT Pintão, LCO Oliveira, LFF Dalmazzo, ...
Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2008
1142008
Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration
RC Ribeiro, E Rego
ASH education program book 2006 (1), 162-168, 2006
1142006
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
EM Rego, HT Kim, GJ Ruiz-Argüelles, MS Undurraga, MR Uriarte, ...
Blood, The Journal of the American Society of Hematology 121 (11), 1935-1943, 2013
1042013
Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene
DC Souza-Costa, VC Sandrim, LF Lopes, RF Gerlach, EM Rego, ...
Atherosclerosis 193 (2), 438-444, 2007
992007
Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR α, PLZF/RAR α or NPM/RAR α
EM Rego, D Ruggero, C Tribioli, G Cattoretti, S Kogan, RL Redner, ...
Oncogene 25 (13), 1974-1979, 2006
852006
Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression‐free survival in multiple myeloma
A Maiolino, VTM Hungria, M Garnica, G Oliveira‐Duarte, LCO Oliveira, ...
American journal of hematology 87 (10), 948-952, 2012
712012
Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia
HC Kwaan, EM Rego
Seminars in thrombosis and hemostasis 36 (08), 917-924, 2010
612010
High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia
AR Lucena-Araujo, FM de Oliveira, SD Leite-Cueva, GA dos Santos, ...
Leukemia research 35 (2), 260-264, 2011
592011
Age‐related changes of lymphocyte subsets in normal bone marrow biopsies
EM Rego, AB Garcia, SR Viana, RP Falcão
Cytometry: The Journal of the International Society for Analytical Cytology …, 1998
571998
In vivo analysis of the role of aberrant histone deacetylase recruitment and RARα blockade in the pathogenesis of acute promyelocytic leukemia
H Matsushita, PP Scaglioni, M Bhaumik, EM Rego, LF Cai, SM Majid, ...
The Journal of experimental medicine 203 (4), 821-828, 2006
552006
The system can't perform the operation now. Try again later.
Articles 1–20